Vitalspan Wire reports on longevity science, peptide therapeutics, clinical research, regulation and the businesses shaping access to them.
We give readers the new fact, the strength of the evidence, the limits of the claim and the source record needed to check our work. We cover genuine scientific progress without turning mechanisms, biomarkers or preclinical findings into treatment promises.
Vitalspan Wire was founded in 2026 and is independently owned and published by Dan Coinburn. Editorial accountability, standards and corrections ultimately sit with the publisher.
The publication is currently founder-funded. It does not currently accept sponsored articles, paid placement, affiliate commissions or gifts tied to coverage. Any future material revenue relationship will be disclosed here and beside affected coverage.
Codex assists with source monitoring, research organization, claim ledgers, first drafts and updates. Its role is disclosed. AI may not invent reporting, represent itself as a human source, or approve its own high-risk medical claims.